News in the Life Sciences Industry

UPPSALA, Sweden, Oct. 13, 2020 /PRNewswire/ -- Prior to the Annual General Meeting (AGM) in 2021, Orexo has appointed a Nomination Committee which represents approximately 44 percent of the number of votes in the company as of September 30, 2020.

STOCKHOLM, Oct. 13, 2020 /PRNewswire/ -- Envirotainer, the global market leader and the by far largest provider of temperature-controlled air freight solutions for pharmaceuticals, today announced that they open up unlimited and free access to shipment data for all their customers. The shipment... Read more ››

Enzymatica has licensed to STADA exclusive rights to market and sell the common cold spray ViruProtect® (ColdZyme®) in Russia, Poland, Ukraine and 11 further countries in the CIS and Central Asia.

The agreement builds on the two companies' existing successful partnership... Read more ››

STOCKHOLM, Oct. 13, 2020 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announced... Read more ››

LUND, Sweden, Oct. 12, 2020 /PRNewswire/ -- TFS recently entered into a strategic partnership with the Duke Clinical Research Institute (DCRI) to provide data management solutions across the academic research organization's study portfolio.

STOCKHOLM, Oct. 12, 2020 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO) today announces that the Company has informed the European Medicines Agency, EMA, about its intention to submit an application for a conditional marketing authorization of melflufen (INN melphalan flufenamide)... Read more ››

LUND, Sweden, Oct. 12, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today that the company's clinical phase IIb study in prostate cancer, a multi-center study with the designation RhoVac-002 ("BRaVac"), is expected to be further delayed due to the prevailing Covid-19 pandemic. The... Read more ››

STOCKHOLM, Oct. 9, 2020 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi(TM)) (STO:SOBI) today announced topline results from its phase 3 study of avatrombopag, an oral thrombopoietin (TPO) receptor agonist, in solid tumour cancer patients with chemotherapy-induced thrombocytopenia (CIT).... Read more ››

STOCKHOLM, Oct. 9, 2020 /PRNewswire/ -- TECHNIA, the #1 knowledge leaders in PLM, announced today that two major OEMs - a Scandinavian leader in the residential property market and a USA supplier of inspection equipment to the semiconductor industry - are selecting "Light My Way" a TECHNIA... Read more ››

STOCKHOLM, Oct. 8, 2020 /PRNewswire/ -- Medical wire that stops the trembling caused by Parkinson's disease. Precision tools that can manufacture tailored prosthetic limbs durable and flexible enough to race down the slopes. And 3D-printing technologies that can create scull and spinal implants... Read more ››

STOCKHOLM, Oct. 8, 2020 /PRNewswire/ -- Oblique Therapeutics AB together with collaborators at Sahlgrenska University Hospital (Gothenburg) and Karolinska Institutet (Stockholm) has been granted 5MSEK by Vinnova to develop neutralizing antibodies towards SARS-CoV-2 and to develop its Abiprot(TM)... Read more ››

STOCKHOLM, Oct. 8, 2020 /PRNewswire/ -- Cantargia AB today announced that all 31 pancreatic cancer (PDAC) patients planned in the CANFOUR trial investigating combination of CAN04 and chemotherapy have started treatment. In the interim data set, no unexpected side effects have been reported,... Read more ››

STOCKHOLM, Oct. 8, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC) today signed an agreement to acquire all assets of the Jacksonville, Florida based MedTech company Eqip, Inc., a health IT cloud services and data analytics startup.

STOCKHOLM, Oct. 8, 2020 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announced that the company... Read more ››

STOCKHOLM, Oct. 7, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the UK's National Institute for Health and Care Excellence (NICE) has issued a Medtech innovation briefing (MIB) on the use of AnaConDa as an alternative to intravenous... Read more ››

STOCKHOLM, Oct. 7, 2020 /PRNewswire/ -- Enzymatica's cold spray ColdZyme® has now been launched in Israel by Chemipal - a leading pharmaceutical distributor in the country. Chemipal will carry out an extensive marketing campaign for ColdZyme involving advertising, radio commercials, digital... Read more ››